Funding awarded
- Precision epigenetic therapy for SETD2+/- B cell lymphomas awarded by Lymphoma Research Foundation Principal Investigator 2023 - 2025
- Role of novel onco-histone mutations in B-cell malignancies awarded by National Cancer Institute Key Personnel 2019 - 2024